Skip to content
LexBuild

Issuance of Final Guidance Publications

---
identifier: "/us/fr/2017-08887"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Issuance of Final Guidance Publications"
title_number: 0
title_name: "Federal Register"
section_number: "2017-08887"
section_name: "Issuance of Final Guidance Publications"
positive_law: false
currency: "2017-05-03"
last_updated: "2017-05-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-08887"
document_type: "notice"
publication_date: "2017-05-03"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "82 FR 20606"
fr_volume: 82
docket_ids:
  - "CDC-2015-0021"
  - "Docket Number NIOSH-153-C"
fr_action: "Notice of issuance of final guidance publications."
---

#  Issuance of Final Guidance Publications

**AGENCY:**

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice of issuance of final guidance publications.

**SUMMARY:**

NIOSH announces the availability of the following final 5 Skin Notation Profiles: Acrylic acid [CAS No. 79-01-7], Dichlorvos [CAS No. 62-73-7], Morpholine [CAS No. 110-91-8], Ethyl p-nitrophenyl phenylphosphorothioate (EPN) [CAS No. 2104-64-5], Dioxathion [CAS No. 78-34-2].

**DATES:**

The final Skin Notation Profiles documents were published on April 10, 2017.

**ADDRESSES:**

These documents may be obtained at the following link: *http://www.cdc.gov/niosh/topics/skin/skin-notation_profiles.html.*

**FOR FURTHER INFORMATION CONTACT:**

Naomi Hudson, Dr. P.H., NIOSH, Education and Information Division (EID), Robert A. Taft Laboratories, 1090 Tusculum Ave. MS-C32, Cincinnati, OH 45226, email: *[email protected].*

**SUPPLEMENTARY INFORMATION:**

On May 1, 2015, NIOSH published a request for public review in the *Federal Register* [80 FR 24932] on skin notation profiles and technical documents. All comments received were reviewed and accepted where appropriate.

Dated: April 27, 2017.

Frank Hearl,

Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.